Guanglin Wu

775 total citations
19 papers, 557 citations indexed

About

Guanglin Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Guanglin Wu has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Guanglin Wu's work include Prostate Cancer Treatment and Research (7 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA Interference and Gene Delivery (3 papers). Guanglin Wu is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA Interference and Gene Delivery (3 papers). Guanglin Wu collaborates with scholars based in United States, China and Greece. Guanglin Wu's co-authors include Sankar N. Maity, Christopher J. Logothetis, Jack A. Roth, Lin Ji, Gitanjali Jayachandran, Wuguo Deng, Ana M. Aparicio, Jiexin Zhang, Patricia Troncoso and Jing‐Fang Lu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Guanglin Wu

19 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanglin Wu United States 9 301 259 137 137 67 19 557
Sharareh Siamakpour‐Reihani United States 11 82 0.3× 246 0.9× 146 1.1× 169 1.2× 53 0.8× 25 531
Feliksas Jankevičius Lithuania 17 296 1.0× 503 1.9× 123 0.9× 309 2.3× 46 0.7× 58 871
Mengwei Wu China 12 163 0.5× 385 1.5× 202 1.5× 270 2.0× 22 0.3× 27 682
Asha Pant United States 8 147 0.5× 154 0.6× 105 0.8× 79 0.6× 31 0.5× 12 433
Michael Ensminger Germany 6 129 0.4× 658 2.5× 226 1.6× 198 1.4× 106 1.6× 7 794
Quynh Nguyen United States 9 162 0.5× 239 0.9× 189 1.4× 54 0.4× 38 0.6× 35 529
Jason Kirk United States 12 133 0.4× 293 1.1× 123 0.9× 136 1.0× 20 0.3× 17 491
Jennifer Doss United States 10 260 0.9× 269 1.0× 205 1.5× 173 1.3× 24 0.4× 10 624
Larry Bodgi Lebanon 14 202 0.7× 271 1.0× 122 0.9× 143 1.0× 274 4.1× 30 567

Countries citing papers authored by Guanglin Wu

Since Specialization
Citations

This map shows the geographic impact of Guanglin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglin Wu more than expected).

Fields of papers citing papers by Guanglin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanglin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglin Wu. The network helps show where Guanglin Wu may publish in the future.

Co-authorship network of co-authors of Guanglin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guanglin Wu. A scholar is included among the top collaborators of Guanglin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanglin Wu. Guanglin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Yue, Guanglin Wu, Xiaoying Hu, Jie Wang, & Guanghong Zhou. (2025). Microfluidic cell carriers for cultured meat. Food Chemistry. 482. 144149–144149. 1 indexed citations
3.
Wu, Guanglin, et al.. (2024). Application of Delaunay adaptive mesh refinement in flood risk assessment of multi-bridge system with short distance. Applied Water Science. 14(6). 1 indexed citations
4.
Wu, Guanglin, et al.. (2023). An experimental study on nonlinear wave dynamics for freak waves over an uneven bottom. Frontiers in Marine Science. 10. 8 indexed citations
6.
Deng, Ziming, et al.. (2022). Engineering Properties of PVA Fibre-Reinforced Geopolymer Mortar Containing Waste Oyster Shells. Materials. 15(19). 7013–7013. 24 indexed citations
7.
Maity, Sankar N., Mark Titus, Guanglin Wu, et al.. (2016). Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer. Scientific Reports. 6(1). 35354–35354. 26 indexed citations
8.
Aparicio, Ana M., Li Shen, Elsa Li Ning Tapia, et al.. (2015). Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers. Clinical Cancer Research. 22(6). 1520–1530. 192 indexed citations
9.
Aparicio, Ana M., Li Shen, Elsa Li Ning Tapia, et al.. (2015). Molecular characterization of clinically defined aggressive variant prostate cancer (AVPCa) in prospectively collected tissues and corresponding patient derived xenografts (PDX).. Journal of Clinical Oncology. 33(15_suppl). 5055–5055. 1 indexed citations
10.
Aparicio, Ana M., Li Shen, Elsa Li Ning Tapia, et al.. (2015). A comprehensive molecular characterization of aggressive variant prostate cancer (PC).. Journal of Clinical Oncology. 33(7_suppl). 149–149. 1 indexed citations
11.
Maity, Sankar N., Guanglin Wu, Jing‐Fang Lu, et al.. (2014). Abstract 3808: Preclinical efficacy of the novel, oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) on castration resistant prostate cancer. Cancer Research. 74(19_Supplement). 3808–3808. 1 indexed citations
12.
Han, Lin, Murali K. Ravoori, Guanglin Wu, et al.. (2013). Somatostatin Receptor Type 2–Based Reporter Expression after Plasmid-Based in Vivo Gene Delivery to Non–Small Cell Lung Cancer. Molecular Imaging. 12(7). 1–10. 7 indexed citations
13.
Maity, Sankar N., Guanglin Wu, Jing‐Fang Lu, et al.. (2013). Abstract 4772: Efficacy of VT-464, a novel selective inhibitor of cytochrome P450 17,20-lyase, in castrate-resistant prostate cancer models.. Cancer Research. 73(8_Supplement). 4772–4772. 2 indexed citations
14.
Κάρλου, Μαρία, Jing‐Fang Lu, Guanglin Wu, et al.. (2012). Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC‐0449 in the bone forming prostate cancer xenograft MDA PCa 118b. The Prostate. 72(15). 1638–1647. 26 indexed citations
15.
Tzelepi, Vassiliki, Jiexin Zhang, Guanglin Wu, et al.. (2011). Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features. Clinical Cancer Research. 18(3). 666–677. 105 indexed citations
16.
Deng, Wuguo, Gitanjali Jayachandran, Guanglin Wu, et al.. (2007). Tumor-specific Activation of Human Telomerase Reverses Transcriptase Promoter Activity by Activating Enhancer-binding Protein-2β in Human Lung Cancer Cells. Journal of Biological Chemistry. 282(36). 26460–26470. 57 indexed citations
18.
Ohtani, Shoichiro, Arifumi Iwamaru, Wuguo Deng, et al.. (2007). Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non–Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy. Cancer Research. 67(13). 6293–6303. 53 indexed citations
19.
Wu, Guanglin, Wuguo Deng, Vikas Kundra, et al.. (2005). A novel synthetic hTERT-Mini-CMV chimera promoter-driven tumor-selective and high-efficiency expression of transgene for systemic cancer gene therapy. Cancer Research. 65. 791–791. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026